Name | Number of supported studies | Average coverage | |
---|---|---|---|
adipocyte | 10 studies | 43% ± 21% | |
epithelial cell of proximal tubule | 8 studies | 36% ± 18% | |
fibroblast | 6 studies | 29% ± 25% | |
podocyte | 6 studies | 85% ± 18% | |
enterocyte | 6 studies | 36% ± 9% | |
precursor B cell | 6 studies | 48% ± 9% | |
pro-B cell | 5 studies | 55% ± 14% | |
alveolar macrophage | 5 studies | 25% ± 10% | |
B cell | 4 studies | 24% ± 6% | |
epithelial cell | 4 studies | 31% ± 9% | |
neutrophil | 3 studies | 25% ± 6% | |
luminal cell of prostate epithelium | 3 studies | 20% ± 3% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
kidney | 3 studies | 21% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 95% | 5669.75 | 232 / 245 | 93% | 54.15 | 469 / 502 |
kidney | 91% | 13321.27 | 81 / 89 | 74% | 29.60 | 663 / 901 |
breast | 99% | 6004.69 | 454 / 459 | 62% | 9.70 | 693 / 1118 |
lung | 96% | 4835.86 | 556 / 578 | 40% | 8.34 | 465 / 1155 |
liver | 74% | 1897.11 | 168 / 226 | 34% | 14.64 | 138 / 406 |
muscle | 97% | 2732.64 | 778 / 803 | 0% | 0 | 0 / 0 |
adipose | 91% | 5238.38 | 1096 / 1204 | 0% | 0 | 0 / 0 |
bladder | 38% | 522.71 | 8 / 21 | 53% | 13.07 | 266 / 504 |
skin | 38% | 38896.13 | 691 / 1809 | 46% | 28.04 | 219 / 472 |
peripheral blood | 75% | 6437.26 | 696 / 929 | 0% | 0 | 0 / 0 |
intestine | 15% | 1986.02 | 143 / 966 | 34% | 6.71 | 178 / 527 |
uterus | 15% | 510.02 | 25 / 170 | 33% | 11.00 | 153 / 459 |
esophagus | 15% | 314.54 | 216 / 1445 | 31% | 6.06 | 57 / 183 |
lymph node | 0% | 0 | 0 / 0 | 41% | 8.70 | 12 / 29 |
stomach | 2% | 78.58 | 8 / 359 | 38% | 8.97 | 109 / 286 |
pancreas | 0% | 5.04 | 1 / 328 | 34% | 4.64 | 60 / 178 |
spleen | 32% | 462.78 | 76 / 241 | 0% | 0 | 0 / 0 |
thymus | 8% | 123.86 | 53 / 653 | 15% | 2.09 | 89 / 605 |
eye | 0% | 0 | 0 / 0 | 21% | 9.46 | 17 / 80 |
adrenal gland | 1% | 16.67 | 3 / 258 | 20% | 3.89 | 46 / 230 |
brain | 16% | 400.04 | 418 / 2642 | 5% | 0.49 | 32 / 705 |
ovary | 2% | 25.93 | 3 / 180 | 17% | 2.38 | 74 / 430 |
tonsil | 0% | 0 | 0 / 0 | 13% | 1.03 | 6 / 45 |
heart | 10% | 120.11 | 83 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 9% | 223.38 | 122 / 1335 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0019233 | Biological process | sensory perception of pain |
GO_0030324 | Biological process | lung development |
GO_0010815 | Biological process | bradykinin catabolic process |
GO_0043627 | Biological process | response to estrogen |
GO_0050435 | Biological process | amyloid-beta metabolic process |
GO_0007611 | Biological process | learning or memory |
GO_0050769 | Biological process | positive regulation of neurogenesis |
GO_0001822 | Biological process | kidney development |
GO_0016485 | Biological process | protein processing |
GO_0090399 | Biological process | replicative senescence |
GO_0046449 | Biological process | creatinine metabolic process |
GO_0042447 | Biological process | hormone catabolic process |
GO_0001890 | Biological process | placenta development |
GO_0071493 | Biological process | cellular response to UV-B |
GO_0097242 | Biological process | amyloid-beta clearance |
GO_0010814 | Biological process | substance P catabolic process |
GO_0071345 | Biological process | cellular response to cytokine stimulus |
GO_0006508 | Biological process | proteolysis |
GO_0150094 | Biological process | amyloid-beta clearance by cellular catabolic process |
GO_1900273 | Biological process | positive regulation of long-term synaptic potentiation |
GO_0030163 | Biological process | protein catabolic process |
GO_0006518 | Biological process | peptide metabolic process |
GO_0061837 | Biological process | neuropeptide processing |
GO_0071492 | Biological process | cellular response to UV-A |
GO_0005903 | Cellular component | brush border |
GO_0030667 | Cellular component | secretory granule membrane |
GO_0098793 | Cellular component | presynapse |
GO_0005886 | Cellular component | plasma membrane |
GO_0045121 | Cellular component | membrane raft |
GO_0031410 | Cellular component | cytoplasmic vesicle |
GO_0016020 | Cellular component | membrane |
GO_0005769 | Cellular component | early endosome |
GO_0070062 | Cellular component | extracellular exosome |
GO_0043025 | Cellular component | neuronal cell body |
GO_0005925 | Cellular component | focal adhesion |
GO_0030425 | Cellular component | dendrite |
GO_0005802 | Cellular component | trans-Golgi network |
GO_0009986 | Cellular component | cell surface |
GO_0008021 | Cellular component | synaptic vesicle |
GO_0045202 | Cellular component | synapse |
GO_0005737 | Cellular component | cytoplasm |
GO_0030424 | Cellular component | axon |
GO_0044306 | Cellular component | neuron projection terminus |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0004175 | Molecular function | endopeptidase activity |
GO_0042277 | Molecular function | peptide binding |
GO_0001786 | Molecular function | phosphatidylserine binding |
GO_0008270 | Molecular function | zinc ion binding |
GO_0004222 | Molecular function | metalloendopeptidase activity |
GO_1901612 | Molecular function | cardiolipin binding |
GO_0070012 | Molecular function | oligopeptidase activity |
GO_0005515 | Molecular function | protein binding |
GO_0008238 | Molecular function | exopeptidase activity |
Gene name | MME |
Protein name | Alternative protein MME Neprilysin-411 (EC 3.4.24.11) MME protein (Membrane metallo-endopeptidase variant 2) (Membrane metalloendopeptidase) Neprilysin-390 (EC 3.4.24.11) Neprilysin Neprilysin (EC 3.4.24.11) (Atriopeptidase) (Common acute lymphocytic leukemia antigen) (CALLA) (Enkephalinase) (Neutral endopeptidase 24.11) (NEP) (Neutral endopeptidase) (Skin fibroblast elastase) (SFE) (CD antigen CD10) Neprilysin (EC 3.4.24.11) (Atriopeptidase) (Enkephalinase) (Neutral endopeptidase 24.11) (Skin fibroblast elastase) |
Synonyms | EPN |
Description | FUNCTION: Thermolysin-like specificity, but is almost confined on acting on polypeptides of up to 30 amino acids . Biologically important in the destruction of opioid peptides such as Met- and Leu-enkephalins by cleavage of a Gly-Phe bond . Catalyzes cleavage of bradykinin, substance P and neurotensin peptides . Able to cleave angiotensin-1, angiotensin-2 and angiotensin 1-9 . Involved in the degradation of atrial natriuretic factor (ANF) and brain natriuretic factor (BNP(1-32)) . Displays UV-inducible elastase activity toward skin preelastic and elastic fibers . . |
Accessions | ENST00000675418.2 C9JDZ3 ENST00000382989.7 ENST00000680282.1 L7Z660 Q3KQS6 P08473 ENST00000492661.5 ENST00000473730 A0A7I2U302 ENST00000473730.6 ENST00000615825.2 ENST00000493237.5 L7ZC27 ENST00000491026 ENST00000680057.1 L8E8E1 B7ZKY6 C9IYX7 ENST00000462745.5 ENST00000491026.6 ENST00000675418 A0A6Q8PFY6 ENST00000460393.6 ENST00000360490.7 |